Andrew Branagan, MD

home / authors / andrew-branagan-md

Articles

Dr. Branagan on Novel Induction Therapies With Transplant in Myeloma

Dr. Branagan on Novel Induction Therapies With Transplant in Myeloma

Andrew Branagan, MD
June 16th 2020

Andrew Branagan, MD, discusses novel induction therapies being used with transplant to improve outcomes in patients with multiple myeloma.

Read More

Dr. Branagan on the Role of Transplant in High-Risk Multiple Myeloma

Dr. Branagan on the Role of Transplant in High-Risk Multiple Myeloma

Andrew Branagan, MD
May 28th 2020

Andrew Branagan, MD, discusses the role of autologous stem cell transplantation in patients with high-risk multiple myeloma.

Read More

Dr. Branagan on the Results of the TOURMALINE-MM3 Trial in Multiple Myeloma

Dr. Branagan on the Results of the TOURMALINE-MM3 Trial in Multiple Myeloma

Andrew Branagan, MD
May 14th 2020

Andrew Branagan, MD, discusses the results of the phase 3 TOURMALINE-MM3 trial in multiple myeloma.

Read More

Dr. Branagan on Tandem Transplants in Multiple Myeloma

Dr. Branagan on Tandem Transplants in Multiple Myeloma

Andrew Branagan, MD
March 3rd 2020

Andrew Branagan, MD, discusses the research tandem transplants in patients with high-risk multiple myeloma.

Read More

Latest Updated Articles

Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data